Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 54 of 54 entries
Sorted by: Best Match Show Resources per page
To the editors: express concern about the recent paper by Song et al.

The European respiratory journal

Brain JD, Kreyling W, Gehr P.
PMID: 20044468
Eur Respir J. 2010 Jan;35(1):226-7. doi: 10.1183/09031936.00159909.

No abstract available.

Cite
Brain JD, Kreyling W, Gehr P. To the editors: express concern about the recent paper by Song et al. Eur Respir J. 2010;35(1):226-7doi: 10.1183/09031936.00159909.
Brain, J. D., Kreyling, W., & Gehr, P. (2010). To the editors: express concern about the recent paper by Song et al. The European respiratory journal, 35(1), 226-7. https://doi.org/10.1183/09031936.00159909
Brain, J D, et al. "To the editors: express concern about the recent paper by Song et al." The European respiratory journal vol. 35,1 (2010): 226-7. doi: https://doi.org/10.1183/09031936.00159909
Brain JD, Kreyling W, Gehr P. To the editors: express concern about the recent paper by Song et al. Eur Respir J. 2010 Jan;35(1):226-7. doi: 10.1183/09031936.00159909. PMID: 20044468.
Copy Download .nbib Format: NLM
[Clinical aspects on lung disorders caused by a virus].

Minerva medica

CAROTTI A.
PMID: 13464612
Minerva Med. 1957 Jun 27;48(51):2255-9.

No abstract available.

Cite
CAROTTI A. Considerazioni cliniche sulle pneumopatie da virus. [Clinical aspects on lung disorders caused by a virus]. Minerva Med. 1957;48(51):2255-9
CAROTTI, A. (1957). Considerazioni cliniche sulle pneumopatie da virus. [Clinical aspects on lung disorders caused by a virus]. Minerva medica, 48(51), 2255-9.
CAROTTI, A. "Considerazioni cliniche sulle pneumopatie da virus." [Clinical aspects on lung disorders caused by a virus]. Minerva medica vol. 48,51 (1957): 2255-9.
CAROTTI A. Considerazioni cliniche sulle pneumopatie da virus. [Clinical aspects on lung disorders caused by a virus]. Minerva Med. 1957 Jun 27;48(51):2255-9. Italian. PMID: 13464612.
Copy Download .nbib Format: NLM
Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage.

Reumatologia clinica

Aguilera-Pickens G, Abud-Mendoza C.
PMID: 29773465
Reumatol Clin (Engl Ed). 2018 Sep - Oct;14(5):294-300. doi: 10.1016/j.reuma.2018.03.012.

Systemic lupus erythematosus is the diffuse autoimmune connective tissue disease that most frequently involves pulmonary involvement, affecting 20% of 90% of the patients. The percentage varies depending on the defining criteria (symptoms, pulmonary tests or histopathological studies). At least...

Cite
Aguilera-Pickens G, Abud-Mendoza C. Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed). 2018;14(5):294-300doi: 10.1016/j.reuma.2018.03.012.
Aguilera-Pickens, G., & Abud-Mendoza, C. (2018). Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatologia clinica, 14(5), 294-300. https://doi.org/10.1016/j.reuma.2018.03.012
Aguilera-Pickens, Georgina, and Abud-Mendoza, Carlos. "Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa." Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatologia clinica vol. 14,5 (2018): 294-300. doi: https://doi.org/10.1016/j.reuma.2018.03.012
Aguilera-Pickens G, Abud-Mendoza C. Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed). 2018 Sep - Oct;14(5):294-300. doi: 10.1016/j.reuma.2018.03.012. Spanish. PMID: 29773465.
Copy Download .nbib Format: NLM
Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease.

Archives of pathology & laboratory medicine

Smith ML.
PMID: 28134583
Arch Pathol Lab Med. 2017 Feb;141(2):223-231. doi: 10.5858/arpa.2016-0098-RA.

CONTEXT: -Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis commonly presents with pulmonary and renal involvement that may present diagnostic challenges.OBJECTIVES: -To highlight the updates in the classification of small vessel vasculitis, present the patterns of pulmonary and renal pathology in which...

Cite
Smith ML. Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease. Arch Pathol Lab Med. 2017;141(2):223-231doi: 10.5858/arpa.2016-0098-RA.
Smith, M. L. (2017). Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease. Archives of pathology & laboratory medicine, 141(2), 223-231. https://doi.org/10.5858/arpa.2016-0098-RA
Smith, Maxwell L. "Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease." Archives of pathology & laboratory medicine vol. 141,2 (2017): 223-231. doi: https://doi.org/10.5858/arpa.2016-0098-RA
Smith ML. Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease. Arch Pathol Lab Med. 2017 Feb;141(2):223-231. doi: 10.5858/arpa.2016-0098-RA. PMID: 28134583.
Copy Download .nbib Format: NLM
Vaping-related lung illnesses: time to act.

The Lancet. Oncology

The Lancet Oncology.
PMID: 31578988
Lancet Oncol. 2019 Oct;20(10):1327. doi: 10.1016/S1470-2045(19)30592-3. Epub 2019 Sep 30.

No abstract available.

Cite
The Lancet Oncology. Vaping-related lung illnesses: time to act. Lancet Oncol. 2019;20(10):1327doi: 10.1016/S1470-2045(19)30592-3.
The Lancet Oncology. (2019). Vaping-related lung illnesses: time to act. The Lancet. Oncology, 20(10), 1327. https://doi.org/10.1016/S1470-2045(19)30592-3
The Lancet Oncology. "Vaping-related lung illnesses: time to act." The Lancet. Oncology vol. 20,10 (2019): 1327. doi: https://doi.org/10.1016/S1470-2045(19)30592-3
The Lancet Oncology. Vaping-related lung illnesses: time to act. Lancet Oncol. 2019 Oct;20(10):1327. doi: 10.1016/S1470-2045(19)30592-3. Epub 2019 Sep 30. PMID: 31578988.
Copy Download .nbib Format: NLM
Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders.

American journal of respiratory and critical care medicine

Vincent M, Karolak JA, Deutsch G, Gambin T, Popek E, Isidor B, Szafranski P, Le Caignec C, Stankiewicz P.
PMID: 31189067
Am J Respir Crit Care Med. 2019 Nov 01;200(9):1093-1101. doi: 10.1164/rccm.201903-0495TR.

Lethal lung developmental disorders are a rare but important group of pediatric diffuse lung diseases presenting with neonatal respiratory failure. On the basis of histopathological appearance at lung biopsy or autopsy, they have been termed: alveolar capillary dysplasia with...

Cite
Vincent M, Karolak JA, Deutsch G, et al. Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders. Am J Respir Crit Care Med. 2019;200(9):1093-1101doi: 10.1164/rccm.201903-0495TR.
Vincent, M., Karolak, J. A., Deutsch, G., Gambin, T., Popek, E., Isidor, B., Szafranski, P., Le Caignec, C., & Stankiewicz, P. (2019). Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders. American journal of respiratory and critical care medicine, 200(9), 1093-1101. https://doi.org/10.1164/rccm.201903-0495TR
Vincent, Marie, et al. "Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders." American journal of respiratory and critical care medicine vol. 200,9 (2019): 1093-1101. doi: https://doi.org/10.1164/rccm.201903-0495TR
Vincent M, Karolak JA, Deutsch G, Gambin T, Popek E, Isidor B, Szafranski P, Le Caignec C, Stankiewicz P. Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders. Am J Respir Crit Care Med. 2019 Nov 01;200(9):1093-1101. doi: 10.1164/rccm.201903-0495TR. PMID: 31189067; PMCID: PMC6888654.
Copy Download .nbib Format: NLM
Showing 49 to 54 of 54 entries